2024-09-23 - Analysis Report
## Pfizer Inc. (PFE) Stock Analysis Report

**Company Overview:** Pfizer Inc. is a multinational pharmaceutical corporation that develops and manufactures medicines and vaccines.

**Performance Summary:**

**1.  Performance vs. S&P 500 (VOO):**

*   **Cumulative Return (PFE):** -11.31%
*   **Cumulative Return (VOO):** 132.53%
*   **Performance Gap:** -143.84% (This means PFE has underperformed VOO by a significant margin)
*   **Relative Performance:** 0.0 (Indicates that PFE's performance is at the lowest point compared to its historical performance relative to VOO).

**2. Recent Price Trend:**

*   **Closing Price:** $29.42
*   **5-day Moving Average:** $29.74
*   **20-day Moving Average:** $29.14
*   **60-day Moving Average:** $29.13

    *   The stock price is currently trading slightly below its 5-day moving average, indicating potential short-term weakness.  The price is also below its 20-day and 60-day moving averages, suggesting a longer-term downtrend.

**3. Technical Indicators:**

*   **RSI:** 54.69 (Neither overbought nor oversold)
*   **PPO:** 0.25 (Positive reading, indicating potential bullish momentum)
*   **Delta_Previous_Relative_Divergence:** -2.34 (Negative, indicating recent short-term weakness)
*   **Expected Return:** 15.25% (Represents the potential 5-year expected return on investment)

**4. Recent Earnings and Outlook:**

| Date       | EPS      | Expected EPS |
|------------|----------|--------------|
| 2024-07-30 | 0.6      | 0.458         |
| 2024-05-01 | 0.82     | 0.516         |
| 2024-01-30 | 0.1      | -0.19         |
| 2023-10-31 | -0.17    | -0.32         |
| 2023-08-01 | 0.67     | 0.56         |

*   **Recent Earnings:** Pfizer's most recent earnings (2024-07-30) beat analyst expectations, coming in at $0.60 per share compared to an expected $0.458. This suggests a positive performance despite the overall market trend.

**Overall Analysis:**

Pfizer's stock performance has lagged behind the broader market in recent times. Despite a recent earnings beat, technical indicators point towards some short-term weakness. However, the positive PPO reading and relatively high expected return could suggest a potential turnaround in the long term.  Investors should carefully consider these factors and monitor the stock's price action and technical indicators for further insights. 

**Note:** This report provides a brief overview of the stock's performance. Further research and due diligence are recommended before making any investment decisions. 
